GD General Dynamics 10-Q 2026-10-04 section summaries

An AI model summarized each section of the report on its own; the summary was written from these. They are longer and less edited than the summary, and the filing on SEC is the authority.

Item 1, Financial Statements

General Dynamics — Q3 and 9M 2026

Consolidated results

Amounts in $ billions, except per-share data. Q3 ended October 4, 2026; comparative periods ended September 28, 2025.

Metric Q3 2026 Q3 2025 9M 2026 9M 2025
Revenue $14.566 $12.907 $42.141 $38.171
Products revenue 9.024 8.021 26.020 23.367
Services revenue 5.542 4.886 16.121 14.804
Product costs 7.558 6.788 21.838 19.752
Service costs 4.759 4.151 13.728 12.609
General and administrative expense 0.722 0.637 2.168 1.906
Operating earnings 1.527 1.331 4.407 3.904
Net interest expense 0.045 0.074 0.163 0.251
Net earnings 1.229 1.059 3.514 3.067
Diluted EPS $4.49 $3.88 $12.83 $11.29

Revenue rose 12.9% in Q3 and 10.4% for 9M; operating earnings increased 14.7% and 12.9%, respectively. Lower net interest expense contributed to net earnings growth of 16.1% in Q3 and 14.6% for 9M.

Segment results

Amounts in $ millions. Segment operating earnings are the company’s segment profit measure; corporate operating costs are shown separately.

Segment Q3 revenue 2026 Q3 revenue 2025 Q3 operating earnings 2026 Q3 operating earnings 2025
Aerospace 3,536 3,234 513 430
Marine Systems 4,960 4,096 391 291
Combat Systems 2,386 2,252 330 335
Technologies 3,684 3,325 346 327
Corporate operating costs — — (53) (52)
Selected 9M segment results 2026 2025
Marine Systems revenue $13,963M $11,905M
Marine Systems operating earnings 1,049 832
Technologies revenue 10,879 10,233

Marine Systems’ Q3 revenue growth of 21.1% exceeded its 9M growth of 17.3%; its operating earnings growth was 34.4% in Q3 versus 26.1% for 9M. Technologies revenue growth was 10.8% in Q3 versus 6.3% for 9M.

Q3 business-line revenues were: Aerospace aircraft manufacturing $2,452M ($2,293M prior year) and aircraft services $1,084M ($941M); Marine nuclear-powered submarines $3,833M ($3,166M) and surface ships $844M ($642M); Combat military vehicles $1,200M ($1,231M) and weapon systems and munitions $831M ($742M); Technologies IT services $2,449M ($2,229M) and C5ISR solutions $1,235M ($1,096M).

Customers, contracts and backlog

For 9M, U.S. government revenue was $28.626B, versus $26.158B; Department of War revenue was $24.186B, versus $21.767B, or about 57% of total revenue. U.S. commercial revenue was $5.151B ($5.186B); non-U.S. government revenue was $3.608B ($3.223B); and non-U.S. commercial revenue was $4.756B ($3.604B). Q3 U.S. government revenue was $10.007B, including $8.534B from the Department of War.

9M revenue by contract type was fixed-price $25.680B ($24.173B), cost-reimbursement $13.565B ($11.654B), and time-and-materials $2.896B ($2.344B). Fixed-price production contracts can benefit results when costs are below estimates but expose the company to cost overruns; the other contract types generally carry different risk and fee structures.

Backlog (remaining performance obligations) was $220.3B at October 4, 2026. The company expects to recognize about 30% as revenue by year-end 2027, another 25% by year-end 2029, and the balance thereafter. Revenue recognized over time was 75% in both Q3 and 9M 2026, compared with 74% in Q3 and 75% in 9M 2025. Contract estimates depend on productivity and labor and material availability, subcontractor performance, and customer funding. Estimate adjustments contributed Q3 revenue of $120M, operating earnings of $44M, and diluted EPS of $0.13, versus $81M, $57M, and $0.17; 9M contributions were $255M, $137M, and $0.40, versus $214M, $119M, and $0.35. A large international tracked-vehicle contract has variable consideration that could be realized below estimates.

Balance sheet, debt and cash flow

Amounts in $ billions; balance-sheet comparisons are October 4, 2026 versus December 31, 2025.

Balance-sheet item Oct. 4, 2026 Dec. 31, 2025
Total assets $60.205 $57.249
Total shareholders’ equity 27.292 25.622
Goodwill 20.849 21.009
Intangible assets, net (excluding goodwill) 1.231 1.375
Implied tangible equity 5.212 3.238
Cash and equivalents 4.388 2.333
Net unbilled receivables 8.906 8.380
Customer advances and deposits 11.083 9.824

Net intangible assets comprised $1,015M of contract/program intangibles, $209M of trade names/trademarks, $7M of technology/software, and no other intangible assets. Technologies held $14.515B of goodwill, net of $1.8B in accumulated impairment losses. Inventory was $9.124B, mainly business-jet aircraft work in process, versus $9.232B.

Debt principal declined to $7.070B from $8.074B; carrying-value debt was $7.016B versus $8.013B, including $6.260B of long-term debt and $756M current debt. Debt fair value was $6.263B versus $7.610B. The company repaid $1B of notes at maturity using cash. No commercial paper was outstanding; a $4B committed credit facility expires in March 2027 and may be renewed or replaced. The company was covenant-compliant.

Cash flow / investment Q3 2026 Q3 2025 9M 2026 9M 2025
Capital expenditures $481M $212M $918M $552M
9M cash flow item 2026 2025
Net earnings $3.514B $3.067B
Operating cash flow 5.745 3.559
Investing cash outflow 0.900 0.422
Financing cash outflow 2.780 2.306

Higher customer advances and deposits provided $1.232B of operating cash in 9M, versus $45M; unbilled receivables used $480M, versus $415M. Cash increased $2.055B to $4.388B. Financing outflows included $1.263B of dividends paid ($1.188B prior year), $1B of fixed-rate note repayments ($1.5B), and $604M of common-stock purchases ($600M).

Other material developments and risks

In August 2026, the SEC and DOJ Civil Division contacted General Dynamics about investigations into Electric Boat’s accounting for submarine contracts. The company later received subpoenas from the DoW Inspector General and SEC regarding cost recording and billing, accounting, and related financial reporting and disclosures. The investigations are ongoing; the company cannot estimate a potential loss, and an adverse outcome could materially affect results, financial condition, and cash flows.

The company repurchased 1.7M shares for $604M in 9M to cover dilution, versus 2.4M shares for $600M in 2025; 5.1M shares remained authorized for repurchase. Diluted weighted-average shares were 273.778M for Q3 and 273.808M for 9M, versus 272.640M and 271.750M. Dividends declared were $1.59 per share in Q3 and $4.77 for 9M, versus $1.50 and $4.50.

Pension net periodic benefit cost rose to $24M in Q3 and $71M for 9M, from $8M and $24M. The company contributed $500M to qualified pension plans in Q3. Pension and other post-retirement costs on U.S. government contracts are recoverable under applicable rules, with timing differences deferred on the balance sheet.

Foreign-exchange forward-contract notional value was $9.1B, up from $8.5B; gains and losses were not material, and the company does not use derivatives for trading or speculation. Q3 net-of-tax other comprehensive loss was $149M ($65M loss prior year); 9M OCI was a $249M loss versus $658M income, largely reflecting currency translation.

Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations

Results

($ millions, except margin) Q3 2026 Q3 2025 9M 2026 9M 2025
Revenue $14,566 $12,907 $42,141 $38,171
Operating costs $13,039 $11,576 $37,734 $34,267
Operating earnings $1,527 $1,331 $4,407 $3,904
Operating margin 10.5% 10.3% 10.5% 10.2%

Revenue grew 12.9% in Q3 and 10.4% in 9M; operating earnings increased 14.7% and 12.9%, respectively. Margin improvement reflected stronger performance in Aerospace and Marine Systems. In Q3, product revenue was $9.024B from $8.021B, while service revenue was $5.542B from $4.886B. For 9M, product revenue was $26.020B from $23.367B and service revenue was $16.121B from $14.804B. Net interest expense declined to $163M from $251M in 9M, mainly due to lower commercial-paper interest expense and higher interest income on cash. Net other income fell to $18M from $51M, largely reflecting pension funded-status improvements after contributions; the effective tax rate rose to 17.6% from 17.2%.

Segment results

Segment ($ millions) Q3 revenue 2026 Q3 revenue 2025 Q3 operating earnings 2026 Q3 operating earnings 2025
Aerospace $3,536 $3,234 $513 $430
Marine Systems $4,960 $4,096 $391 $291
Combat Systems $2,386 $2,252 $330 $335
Technologies $3,684 $3,325 $346 $327
Corporate operating costs — — $53 $52

Marine Systems’ 9M revenue was $13.963B from $11.905B and operating earnings were $1.049B from $832M; Q3 growth accelerated versus 9M in both revenue and earnings. Higher Columbia- and Virginia-class submarine labor and material volume drove results; earnings also benefited from improved performance and a favorable Virginia-class Block IV adjustment as that program nears completion. Technologies’ 9M revenue was $10.879B from $10.233B, with operating earnings of $1.024B from $987M; revenue growth was slower in Q3 than 9M. C5ISR and IT-services volume increased, while program mix pressured margins.

Aerospace’s Q3 margin rose to 14.5% from 13.3%; 9M revenue was $10.340B from $9.322B and operating earnings $1.516B from $1.265B. Deliveries were 40 aircraft versus 39 in Q3 (119 versus 113 in 9M). Growth reflected more deliveries, favorable aircraft mix, and higher services, FBO and maintenance activity; selling expenses also increased. Combat Systems’ Q3 margin fell to 13.8% from 14.9%; 9M revenue was $6.959B from $6.711B and operating earnings $958M from $950M. Artillery growth was partly offset by lower U.S. military-vehicle revenue and program mix; reduced U.S. Army demand during recapitalization and termination of the M10 Booker program weighed on results. Technologies’ Q3 margin was 9.4% versus 9.8% (9M: 9.4% versus 9.6%). Corporate costs primarily reflected equity compensation and miscellaneous expenses.

Backlog, outlook and business developments

Total backlog reached $220.339B at October 4, 2026, up from $136.498B at July 5, comprising $111.796B funded and $108.543B unfunded. Marine Systems backlog rose to $146.865B from $65.182B, including $99.576B unfunded versus $22.826B. Aerospace backlog was $25.385B from $23.977B; Combat Systems, $28.684B from $29.350B; and Technologies, $19.405B from $17.989B. Including $50.330B of estimated potential contract value, total estimated contract value was $270.669B versus $186.902B.

Defense backlog was approximately $195B, up 73% from $112.5B at Q2-end, primarily due to large Virginia- and Columbia-class submarine awards. Defense book-to-bill was 8.5x in Q3 and 4.1x in 9M; estimated potential defense contract value was $49B. These potential values include estimated unfunded IDIQ work and unexercised options, not solely firm orders; unfunded backlog depends on future appropriations. Aerospace book-to-bill was 1.4-to-1 in both Q3 and 9M, reflecting strong Gulfstream demand; its estimated potential contract value was $1.4B.

The 2026 outlook is revenue of $56.5B–$56.8B, operating margin around 10.5%, net interest expense about $215M and diluted EPS of $17.20–$17.30. Strong Navy submarine demand is driving capacity and workforce investment, while shipbuilding supply-chain and skilled-labor constraints remain challenges. Management expects slightly lower near-term combat-vehicle production as the Army shifts priorities; munitions and European demand provide opportunities but add supply and hiring pressure. Gulfstream demand is strong, though aircraft output faces supplier delays, including one tied to conflict-related disruption at an Israel-based supplier. Inflation and tariffs affect Aerospace; IEEPA tariff refunds received were not material overall, and timing of remaining refunds is uncertain. Sanctions continue to restrict access to the Russian business-aviation market. A continuing resolution funds agencies through December 11, 2026, generally at prior-year levels and restricting new or increased programs; management did not expect a material near-term impact.

Cash flow, liquidity and capital deployment

($ millions) 9M 2026 9M 2025
Operating cash flow $5,745 $3,559
Investing cash flow $(900) $(422)
Financing cash flow $(2,780) $(2,306)
Capital expenditures $918 $552
Free cash flow $4,827 $3,007

Operating cash flow benefited from lower working capital, particularly in Combat Systems and Aerospace, and included a $500M qualified-pension contribution. Capex increased 66% and is expected to remain elevated in Q4. Operating cash flow/net earnings was 163% versus 116%, and free cash flow/net earnings was 137% versus 98%. Cash was $4.4B at Q3-end versus $2.3B at year-end 2025. The company repaid $1.0B of fixed-rate notes at maturity during Q2 and Q3 using cash; it had no commercial paper outstanding at October 4. A $4B committed credit facility expires in March 2027 and may be renewed or replaced; the company also has an effective shelf registration for debt issuance.

Dividends paid were $1.3B in 9M versus $1.2B; the quarterly dividend increased to $1.59 per share in March 2026, the 29th consecutive annual increase, from $1.50 set in March 2025. Share repurchases to cover dilution were approximately $600M in each nine-month period; 5.1M shares, or 1.9% of shares outstanding, remained authorized.

Estimates and guarantor information

Long-term contract estimate revisions under the cumulative catch-up method increased operating earnings/diluted EPS by $44M/$0.13 in Q3 2026 and $137M/$0.40 in 9M 2026, versus $57M/$0.17 and $119M/$0.35 in the corresponding 2025 periods. No individual adjustment was material; actual results may differ from estimates for these multi-year contracts.

Combined parent-and-guarantor 9M 2026 revenue was $17.059B and net earnings $944M (the cited 2025 comparison is full-year: $20.716B revenue and $839M net earnings, and is not directly comparable). At October 4, 2026, combined assets were $13.705B, liabilities $13.150B and implied equity $555M, versus $11.290B, $13.822B and $(2.532)B, respectively, at December 31, 2025. Parent debt service depends on subsidiaries’ ability to distribute cash; notes are unsecured and jointly and severally guaranteed by specified wholly owned subsidiaries, subject to legal limits and release provisions.

Item 3, Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The company reported no material changes in its quantitative or qualitative market-risk disclosures from those in its Form 10-K for the year ended December 31, 2025. No new market-risk exposures, metrics, or developments were reported in this section.

Item 4, Controls and Procedures

Controls and forward-looking statements

As of October 4, 2026, General Dynamics’ CEO and CFO concluded that the company’s disclosure controls and procedures were effective. During the quarter ended October 4, 2026, no changes materially affected, or were reasonably likely to materially affect, internal control over financial reporting. The CEO and CFO’s Section 302 certifications were filed as report exhibits.

Forward-looking statements address matters including revenue, earnings, margins, segment performance, cash flows, contract awards, aircraft production and deliveries, and backlog. These statements are estimates, not guarantees, and actual results may differ materially. Key risks include political and economic conditions; U.S. defense-budget reductions or changing priorities; government contract terminations; program cost or performance shortfalls and supplier issues; uncertainty in recovering contract claims; business-aircraft demand and economic sensitivity; energy and raw-material price changes; pandemics; legal, regulatory, government-investigation and litigation outcomes; government audits of contract performance, compliance and controls; cybersecurity events and disruptions; acquisition and joint-venture risks; and potential climate-related regulation. The company does not undertake to update forward-looking statements after the report date.

This section provides no financial performance metrics.

Part II Item 1A, Risk Factors

No material changes were reported to the risk factors previously disclosed in General Dynamics’ Form 10-K for the year ended December 31, 2025.

Part II Item 5, Other Information

During the quarter ended October 4, 2026, no directors or officers adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement. This section reports no financial or business developments.

Feedback